TSX:MHCD Holdings Information

TSX:MHCD is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 7.04%, Johnson & Johnson at 6.09%, AbbVie at 4.83%, Merck & Co. at 4.58%, and AstraZeneca at 4.22%.

Total Holdings

Top 10 Percentage

42.34%

Asset Class

Equity

ETF Category

Health Care

Assets

151.58M

PE Ratio

24.34

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.04%	6,600
2	JNJ	Johnson & Johnson	6.09%	28,000
3	ABBV	AbbVie Inc.	4.83%	23,000
4	MRK	Merck & Co., Inc.	4.58%	40,000
5	LON: AZN	AstraZeneca PLC	4.22%	23,500
6	TMO	Thermo Fisher Scientific Inc.	3.95%	8,300
7	SYK	Stryker Corporation	3.09%	10,500
8	ISRG	Intuitive Surgical, Inc.	2.91%	7,100
9	TSX: EXE	Extendicare Inc.	2.84%	125,000
10	DHR	Danaher Corporation	2.79%	15,800
11	SWX: NOVN	Novartis AG	2.77%	19,000
12	TSX: CSH.UN	Chartwell Retirement Residences	2.70%	191,000
13	UNH	UnitedHealth Group Incorporated	2.57%	7,000
14	ABT	Abbott Laboratories	2.40%	29,000
15	MDT	Medtronic plc	2.35%	33,000
16	SWX: ROP	Roche Holding AG	2.28%	5,600
17	VRTX	Vertex Pharmaceuticals Incorporated	2.25%	5,200
18	BMY	Bristol-Myers Squibb Company	2.15%	39,000
19	PFE	Pfizer Inc.	2.05%	81,000
20	MCK	McKesson Corporation	2.01%	2,800
21	GILD	Gilead Sciences, Inc.	1.95%	15,000
22	n/a	Cash & Other	1.89%	n/a
23	EPA: SAN	Sanofi	1.87%	22,000
24	NTRA	Natera, Inc.	1.72%	8,000
25	AMGN	Amgen Inc.	1.72%	5,300

Showing 25 of 45 holdings

Subscribe to see the full list

Activate Now

As of May 31, 2026